Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent for Astrazeneca Ab drug FARXIGA appeared first …
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from five suppliers. There are four patents…
The post New patent for Indivior Inc drug SUBOXONE appeared first on…
Annual Drug Patent Expirations for ZYPITAMAG Zypitamag is a drug marketed by Zydus Pharms Usa Inc and is included in one NDA. The generic ingredient in ZYPITAMAG is pitavastatin magnesium.…
The post New patent for Zydus Pharms drug ZYPITAMAG appe…
Annual Drug Patent Expirations for BAXDELA Baxdela is a drug marketed by Melinta Theraps Inc and is included in two NDAs. It is available from one supplier. There are eight…
The post New patent for Melinta Theraps drug BAXDELA appeared first on D…
Annual Drug Patent Expirations for QUILLICHEW+ER Quillichew Er is a drug marketed by Pfizer Inc and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Pfizer Inc drug QUILLICHEW ER appeared first on…
Annual Drug Patent Expirations for PANCREAZE Pancreaze is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Janssen Pharms drug PANCREAZE appeared f…
Annual Drug Patent Expirations for PROCYSBI Procysbi is a drug marketed by Horizon Pharma Usa and is included in one NDA. It is available from two suppliers. There are five…
The post New patent for Horizon Pharma drug PROCYSBI appeared first on D…
Annual Drug Patent Expirations for CYCLOSET Cycloset is a drug marketed by Veroscience and is included in one NDA. It is available from one supplier. There are ten patents protecting…
The post New patent for Veroscience drug CYCLOSET appeared fir…
Annual Drug Patent Expirations for ADLYXIN Adlyxin is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent for Sanofi-aventis Us drug ADLYXIN appeared first…
Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are twenty…
The post New patent for Sanofi-aventis Us drug SOLIQUA 100…